Thyroid cancer

ME Cabanillas, DG McFadden, C Durante - The Lancet, 2016 - thelancet.com
Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over
62 000 new cases occurred in men and women in 2015. The incidence continues to rise …

Omics sciences and precision medicine in thyroid cancer

K Dhuli, MC Medori, K Donato, PE Maltese… - La Clinica …, 2023 - ricerca.unich.it
Background: Thyroid cancer, a heterogeneous disease originating from the thyroid gland,
stands as the predominant endocrine malignan-cy worldwide. Despite advances in …

Thyroid nodules

KD Burman, L Wartofsky - New England Journal of Medicine, 2015 - Mass Medical Soc
Key Clinical Points Thyroid Nodules Thyroid nodules are common; the majority are benign.
Thyroid ultrasonographic characteristics and especially the results of ultrasonographically …

A proposed grading scheme for medullary thyroid carcinoma based on proliferative activity (Ki-67 and mitotic count) and coagulative necrosis

TL Fuchs, AJ Nassour, A Glover… - The American journal …, 2020 - journals.lww.com
We investigated the prognostic value of a range of histologic parameters in medullary
thyroid carcinoma (MTC) to design a grading system to predict overall survival. We assessed …

Doxycycline increases neurogenesis and reduces microglia in the adult hippocampus

S Sultan, E Gebara, N Toni - Frontiers in neuroscience, 2013 - frontiersin.org
Adult hippocampal neurogenesis results in the continuous formation of new neurons and is
a process of brain plasticity involved in learning and memory. Although inducible-reversible …

Diagnosis and management of nodular thyroid disease

O Senashova, M Samuels - Techniques in Vascular and Interventional …, 2022 - Elsevier
Thyroid nodules are common and often asymptomatic. However, patients may seek
treatment for nonfunctional benign nodules that cause compressive symptoms or cosmetic …

Novel prognostic nomogram for predicting recurrence‐free survival in medullary thyroid carcinoma

YA Aksoy, B Xu, K Viswanathan, MS Ahadi… - …, 2024 - Wiley Online Library
Aims Recently, there have been attempts to improve prognostication and therefore better
guide treatment for patients with medullary thyroid carcinoma (MTC). In 2022, the …

Non-medullary thyroid cancer susceptibility genes: evidence and disease spectrum

J Zhou, P Singh, K Yin, J Wang, Y Bao, M Wu… - Annals of surgical …, 2021 - Springer
Background The prevalence of non-medullary thyroid cancer (NMTC) is increasing
worldwide. Although most NMTCs grow slowly, conventional therapies are less effective in …

NOP53 as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer

A Orois, SK Gara, M Mora, I Halperin, S Martínez… - Genes, 2019 - mdpi.com
Nonsyndromic familial non-medullary thyroid cancer (FNMTC) represents 3–9% of thyroid
cancers, but the susceptibility gene (s) remain unknown. We designed this multicenter study …

SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules: initial work-up for thyroid nodules

C Do Cao, M Haissaguerre, C Lussey-Lepoutre… - Annales d' …, 2022 - Elsevier
Abstract The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid
nodules, a condition that is a frequent reason for consultation in endocrinology. In more than …